IP Library Assignment 039076/0377
Patent Assignment
Reel/Frame 039076/0377

Assignment of Assignor's Interest

Recorded: 2016-07-05 Pages: 10
Assignor
TABUTEAU, HERRIOT
Executed: 2016-06-14
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties (14)
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Application: 14/336,642 →
Publication: US US20140329773A1
Substituted Imidazolium Compounds for Treating Disease
Patent: 9,006,279 →
Application: 14/446,184 →
Treatment of Pain with Oral Dosage Forms Comprising Zoledronic Acid and An Enhancer
Application: 14/456,939 →
Publication: US US20140348916A1
Zoledronic Acid Dosage Forms for the Treatment of Pain
Application: 14/457,659 →
Publication: US US20140349974A1
Therapeutic Compositions Comprising Imidazole and Imidazolium Compounds
Patent: 8,962,599 →
Application: 14/481,097 →
Compositions Comprising Rank/Rankl Antagonists and Related Compounds for Treating Pain
Patent: 9,127,069 →
Application: 14/495,732 →
Administration of Zoledronic Acid to Treat Back Pain Associated with Ankylosing Spondylitis
Application: 14/530,556 →
Publication: US US20150051175A1
Inhibitors of Osteoclast Activity for Treating Arthritis
Application: 14/536,526 →
Publication: US US20150057250A1
Compositions Comprising Rank/Rankl Antagonists and Related Compounds for Treating Pain
Patent: 9,290,575 →
Application: 14/538,709 →
Publication: US US20150361179A1
Therapeutic Compositions Comprising Imidazole and Imidazolium Compounds
Patent: 9,216,168 →
Application: 14/540,333 →
Publication: US US20150344505A1
Compositions and Methods for Reducing Dextrorphan Plasma Levels and Related Pharmacodynamic Effects
Patent: 9,198,905 →
Application: 14/550,618 →
Publication: US US20150126541A1
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Application: 14/554,947 →
Publication: US US20150126542A1
Compositions and Methods Comprising Erythrohydroxybupropion and Related Compounds for Improving the Efficacy of Dextromethorphan
Patent: 9,205,083 →
Application: 14/554,988 →
Publication: US US20150126543A1
Compositions and Methods Comprising Bupropion or Related Compounds for Sustained Delivery of Dextromethorphan
Patent: 9,238,032 →
Application: 14/555,085 →
Publication: US US20150126544A1
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 13, 2014
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 033531/0045 →
Assignment of Assignor's Interest Sep 10, 2014
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 033708/0273 →
Assignment of Assignor's Interest Oct 15, 2014
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 033956/0648 →
Assignment of Assignor's Interest Nov 12, 2014
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 034154/0493 →
Assignment of Assignor's Interest Dec 18, 2014
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 034547/0531 →
Assignment of Assignor's Interest Jul 6, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 035980/0996 →
Assignment of Assignor's Interest Jul 6, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 035980/0888 →
Assignment of Assignor's Interest Jul 6, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 035980/0897 →
Assignment of Assignor's Interest Nov 11, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 037017/0195 →